Skip to main content
Fig. 3 | Pediatric Rheumatology

Fig. 3

From: Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center

Fig. 3

Myeloid-related protein 8/14 levels according to methotrexate treatment and outcome at 1 year. Myeloid-related protein (MRP) 8/14 measured at JIA diagnosis in serum (S-MRP8/14) (A) and in plasma (P-MRP8/14) (B) in the treatment groups according to methotrexate (MTX) treatment and remission at 1 year after the diagnosis: JIA patients without DMARDs, in remission on MTX, and no remission on MTX. Each symbol represents the value of a given parameter for an individual patient. Results are given in terms of mean and standard deviation (SD)

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096